Loading...
XLONAAVC
Market cap67mUSD
Dec 06, Last price  
40.00GBP
Name

Albion Venture Capital Trust PLC

Chart & Performance

D1W1MN
XLON:AAVC chart
P/E
P/S
EPS
Div Yield, %
0.05%
Shrs. gr., 5y
10.14%
Rev. gr., 5y
-31.66%
Revenues
-3m
L
3,384,00000000001,262,0001,542,0003,710,0004,454,0007,429,0005,212,0007,277,000-3,427,0007,628,0006,371,000560,000-3,244,000
Net income
-5m
L
2,106,0002,137,0002,010,0001,503,0001,180,0001,003,000870,000745,000930,0001,164,0003,382,0004,015,0007,011,0004,783,0006,771,000-3,941,0007,158,0005,961,000125,000-4,923,000
CFO
-122k
L-63.91%
1,007,0001,012,0001,236,000954,0001,187,000459,000879,000654,000411,000482,000862,0004,015,0007,011,0004,783,0001,273,0001,064,0001,104,000-876,000-338,000-122,000
Dividend
Jul 04, 20241.1199999999999999 GBP/sh
Earnings
Jul 10, 2025

Profile

Albion Venture Capital Trust PLC is a venture capital trust. It does not invest in companies that deal in property or shares and securities, insurance, banking, agriculture. The fund's investments are normally structured as a mixture of equity and loan stock, with a majority of loan stock. Its portfolio company gross assets must not exceed £15 million ($18.67 million) immediately prior to the investment and £16 million ($19.92 million) immediately thereafter. The fund seeks to invest in qualifying quoted and unquoted companies. It seeks to make investments in healthcare and environmental sectors in the United Kingdom. It seeks to hold 50 percent stake in the portfolio company. The fund typically holds its investments for a period of five years. It invests in shares or securities including loans with a five year or greater maturity period. It invests alongside selected partners with experience in the sectors concerned. Other than the loan stock issued by the fund, portfolio companies do not normally have external borrowings.
IPO date
Feb 05, 1997
Employees
0
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
(3,244)
-679.29%
560
-91.21%
6,371
-16.48%
Cost of revenue
2,885
(784)
(808)
Unusual Expense (Income)
NOPBT
(6,129)
1,344
7,179
NOPBT Margin
188.93%
240.00%
112.68%
Operating Taxes
125
(1,000)
Tax Rate
9.30%
NOPAT
(6,129)
1,219
7,180
Net income
(4,923)
-4,038.40%
125
-97.90%
5,961
-16.72%
Dividends
(2,906)
(2,758)
(21,589)
Dividend yield
Proceeds from repurchase of equity
(1,514)
9,911
6,728
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
654
261
Net debt
(62,599)
(69,709)
(62,272)
Cash flow
Cash from operating activities
(122)
(338)
(876)
CAPEX
Cash from investing activities
(2,943)
(8,591)
(3,122)
Cash from financing activities
(4,019)
7,147
(14,896)
FCF
(4,823)
1,578
6,286
Balance
Cash
15,802
22,886
24,668
Long term investments
46,797
46,823
37,604
Excess cash
62,761
69,681
61,953
Stockholders' equity
39,571
120,468
117,805
Invested Capital
22,438
1,334
1,984
ROIC
73.49%
479.31%
ROCE
1.89%
11.23%
EV
Common stock shares outstanding
139,496
123,939
103,266
Price
Market cap
EV
EBITDA
(6,129)
1,344
7,179
EV/EBITDA
Interest
Interest/NOPBT